Effects of progressive resistance training in individuals with type 2 diabetic polyneuropathy: a randomised assessor-blinded controlled trial

• Published in: Diabetologia Vol. 65; no. 4; pp. 620 - 631
• Main Authors: Khan, Karolina S., Overgaard, Kristian, Tankisi, Hatice, Karlsson, Pall, Devantier, Louise, Gregersen, Søren, Jensen, Troels S., Finnerup, Nanna B., Pop-Busui, Rodica, Dalgas, Ulrik, Andersen, Henning
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.04.2022; Springer Nature B.V
• Subjects: Adaptation; Adult; Ankle; Comparative analysis; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - therapy; Diabetic Neuropathies - therapy; Diabetic neuropathy; Exercise; Human Physiology; Humans; Internal Medicine; Knee; Medicine; Medicine & Public Health; Metabolic Diseases; Muscle strength; Muscle Strength - physiology; Physical training; Polyneuropathy; Resistance Training - methods; Strength training; Denmark; Aarhus Denmark; Diabetic polyneuropathy; Exercise; Muscle strength; Motor function; Progressive resistance training; Small nerve fibre structure
• ISSN: 0012-186X; 1432-0428; 1432-0428
• DOI: 10.1007/s00125-021-05646-6

Aims/hypothesis The aim of this study was to evaluate the effects of progressive resistance training (PRT) on muscle strength, intraepidermal nerve fibre density (IENFD) and motor function in individuals with type 2 diabetic polyneuropathy (DPN) and to compare potential adaptations to those of individuals with type 2 diabetes without DPN and healthy controls. Methods This was an assessor-blinded trial conducted at the Neurology department, Aarhus University Hospital. Adults with type 2 diabetes, with and without DPN and healthy control participants were randomised to either supervised PRT or non-PRT for 12 weeks. Allocation was concealed by a central office unrelated to the study. The co-primary outcomes were muscle strength in terms of the peak torque of the knee and ankle extensors and flexors, and IENFD. Secondary outcome measures included the 6 min walk test (6MWT), five-time sit-to-stand test (FTSST) and postural stability index obtained by static posturography. Results A total of 109 individuals were enrolled in three groups (type 2 diabetes with DPN [ n = 42], type 2 diabetes without DPN [ n = 32] and healthy control [ n = 35]). PRT resulted in muscle strength gains of the knee extensors and flexors in all three groups using comparative analysis (DPN group, PRT 10.3 ± 9.6 Nm vs non-PRT −0.4 ± 8.2 Nm; non-DPN group, PRT 7.5 ± 5.8 Nm vs non-PRT 0.6 ± 8.8 Nm; healthy control group, PRT 6.3 ± 9.0 Nm vs non-PRT −0.4 ± 8.4 Nm; p <0.05, respectively). Following PRT the DPN group improved the 6MWT (PRT 34.6 ± 40.9 m vs non-PRT 2.7 ± 19.6 m; p =0.001) and the FTSST (PRT −1.5 ± 2.2 s vs non-PRT 1.5 ± 4.6 s; p =0.02). There was no change in IENFD following PRT in any of the groups. Conclusions/interpretation PRT improved muscle strength of the knee extensors and flexors and motor function in individuals with type 2 diabetic polyneuropathy at levels comparable with those seen in individuals with diabetes without DPN and healthy control individuals, while no effects were observed in IENFD. Trial registration ClinicalTrials.gov NCT03252132 Funding Research reported in this paper is part of the International Diabetic Neuropathy Consortium (IDNC) research programme, supported by a Novo Nordisk Foundation Challenge Program grant (grant no. NNF14OC0011633) and Aarhus University Graphical abstract